Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.
Category: Drugs (Pharmaceuticals)
-
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act.
-
Opioid Settlement Money Is Being Spent on Police Cars and Overtime
As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.
-
Should Opioid Settlement Money Be Spent on Law Enforcement?
As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.
-
Research Trials Halted at Columbia’s Psychiatric Center After Suicide
Human research trials at the New York State Psychiatric Institute at Columbia have been paused while regulators review whether protocols were violated.
-
FDA Approves First Pill for Postpartum Depression
Because the pill works faster than other antidepressants and is taken for only two weeks, it may encourage more treatment of the debilitating condition.
-
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
-
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.
-
Tornado Rips Through N.C. Site, Threatening Pfizer’s Drug Supplies
Extensive damage occurred at the company’s property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.
-
RSV Shot Is Approved for Infants
The respiratory virus is a global killer of babies and young children.
-
Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
-
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill
The price of the pill, which has not been announced, will determine how affordable it will be when it becomes available in early 2024.